BRIEF published on 02/12/2025 at 11:35, 1 year 4 months ago Sensorion to Participate in ARO 48th Annual Midwinter Meeting Sensorion Hearing Loss ARO Meeting GJB2-GT Therapy Biotech Conference
BRIEF published on 02/12/2025 at 11:35, 1 year 4 months ago Sensorion participera à la 48e réunion annuelle de mi-hiver de l'ARO Sensorion Perte Auditive Réunion De L'ARO Thérapie GJB2-GT Conférence Sur Les Biotechnologies
PRESS RELEASE published on 02/12/2025 at 11:30, 1 year 4 months ago Inside Information / Other news releases Sensorion announces participation in ARO 48th Annual Midwinter Meeting with focus on gene therapy for deafness. Details of presentations by Sensorion executives included Gene Therapy Sensorion ARO Meeting Deafness Sensorion Executives
PRESS RELEASE published on 02/12/2025 at 11:30, 1 year 4 months ago Informations privilégiées / Autres communiqués Sensorion participe à la 48ème rencontre annuelle de l'ARO pour présenter ses thérapies novatrices contre la perte auditive Sensorion Perte Auditive Thérapies ARO Rencontre Annuelle
BRIEF published on 12/27/2024 at 07:35, 1 year 5 months ago Sensorion Completes Enrollment for Audiogene Phase 1/2 Trial Gene Therapy Sensorion Hearing Loss SENS-501 Audiogene Trial
BRIEF published on 12/27/2024 at 07:35, 1 year 5 months ago Sensorion finalise le recrutement pour l'essai de phase 1/2 d'Audiogene Thérapie Génique Sensorion Perte Auditive SENS-501 Essai Audiogene
PRESS RELEASE published on 12/27/2024 at 07:30, 1 year 5 months ago Inside Information / Other news releases Sensorion completes enrollment of the first cohort in the Audiogene Phase 1/2 gene therapy clinical trial, targeting infants with hearing loss disorders Gene Therapy Clinical Trial Sensorion Hearing Loss Disorders Audiogene
BRIEF published on 12/18/2024 at 07:35, 1 year 6 months ago Sensorion présente des résultats préliminaires positifs pour le SENS-501 Essai Clinique Thérapie Génique Innovation Biotechnologique SENS-501 Surdité Congénitale
BRIEF published on 12/18/2024 at 07:35, 1 year 6 months ago Sensorion Reports Positive Preliminary Results for SENS-501 Gene Therapy Clinical Trial SENS-501 Congenital Deafness Biotechnological Innovation
PRESS RELEASE published on 12/18/2024 at 07:30, 1 year 6 months ago Informations privilégiées / Autres communiqués Sensorion présente des données positives de l'essai clinique de Phase 1/2 de thérapie génique pour la surdité chez les nourrissons. Nouvelles données encourageantes sur SENS-501. Séminaire en ligne prévu pour 2025 Sécurité Thérapie Génique Phase 1/2 Sensorion Surdité
Published on 06/19/2026 at 04:30, 12 hours 42 minutes ago Uraniumx Discovery Corp. Announces Acquisition of Common Shares of Gold'n Futures Mineral Corp
Published on 06/19/2026 at 01:20, 15 hours 52 minutes ago American Hotel Income Properties REIT LP Reports Voting Results of Annual and Special Meeting
Published on 06/19/2026 at 01:07, 16 hours 5 minutes ago Usha Resources Announces Share Issuance in Payment of Debenture Interest, Adopts Semi-Annual Reporting
Published on 06/19/2026 at 00:00, 17 hours 12 minutes ago Redwood AI Announces Initiation of Chemical Risk Assessment Module
Published on 06/19/2026 at 16:30, 42 minutes ago Amrize to Modernize Montreal Area Cement Plant to be Most Advanced in Eastern Canada
Published on 06/19/2026 at 16:13, 58 minutes ago Projet Transports '45: les priorités discutables du Conseil fédéral pour l'étape d'aménagement 2027
Published on 06/19/2026 at 16:05, 1 hour 6 minutes ago ETOE Launches Dolphin 2 Portable RGB Triple-Laser Projector with Google TV
Published on 06/19/2026 at 15:48, 1 hour 23 minutes ago Halfords Group PLC: Engage Retail Investor event - 25th June 12.00 BST
Published on 06/19/2026 at 15:44, 1 hour 27 minutes ago 2CRSi SA: Webinaire d’information et d’échanges pour les actionnaires individuels suite au document publié par Grizzly Research 19 juin 2026 – 18h
Published on 06/19/2026 at 14:40, 2 hours 31 minutes ago 260619 BENETEAU Mise en oeuvre Programme rachat d'actions
Published on 06/19/2026 at 08:55, 8 hours 17 minutes ago ALPOU - Groupe POULAILLON - Communiqué mise à disposition de la note d'information et DAI relatif à la société visée
Published on 06/19/2026 at 08:55, 8 hours 17 minutes ago ALPOU - Groupe POULAILLON - Communiqué mise à disposition de la note d'information et DAI relatif à EUGENIE
Published on 06/19/2026 at 08:49, 8 hours 22 minutes ago Groupe DLSI - Evolution de la gouvernance et recomposition du Directoire
Published on 06/18/2026 at 18:00, 23 hours 12 minutes ago Publication du nombre d’actions composant le capital et du nombre total de droits de vote au 31 mai 2026
